ChemoCentryx
CCXI
#3639
Rank
S$4.75 B
Marketcap
S$66.14
Share price
0.00%
Change (1 day)
24.32%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: S$4.75 Billion

On November 25, 2022 ChemoCentryx had a market cap of S$4.75 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022S$5.01 B45.41%
2021S$3.44 B-39.2%
2020S$5.66 B76.52%
2019S$3.21 B325.42%
2018S$0.75 B94.53%
2017S$0.38 B-24.2%
2016S$0.51 B1.13%
2015S$0.50 B29.12%
2014S$0.39 B24.62%
2013S$0.31 B-35.31%
2012S$0.48 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$696.49 B 14,542.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$191.23 B 3,920.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$501.39 B 10,441.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$234.18 B 4,823.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$33.57 B 605.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$350.37 B 7,266.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.56 B 2,897.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$132.66 B 2,689.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$49.73 B 945.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel